we have
Pitolisant hcl CAS: 903576-44-3in stock
As the search for effective treatments for sleep disorders intensifies, one compound has emerged as a game-changer in the field - Pitolisant. In this article, we delve into the captivating world of Pitolisant, its potential therapeutic applications, mechanism of action, safety profile, and the exciting possibilities it holds for the future of wakefulness promotion.
Pitolisant - A Glimpse into the Future:
In recent years, Pitolisant has gained significant attention as a novel and promising wakefulness-promoting agent. With its unique mechanism of action and ability to regulate the sleep-wake cycle, Pitolisant has the potential to revolutionize the treatment of sleep disorders, particularly narcolepsy and its associated symptoms.
Exploring the Chemical Marvel:
Pitolisant, also known by its scientific name BF2.649, possesses a molecular structure (C18H20F3N3O3S) that sets it apart from traditional wakefulness-promoting agents. Its distinctive formula weight of 419.43 highlights the precise fusion of chemical constituents that contribute to its remarkable properties.
Unveiling the CAS Number:
CAS: 903576-44-3, the unique Chemical Abstracts Service (CAS) number assigned to Pitolisant, is a testament to its individuality and distinct pharmacological profile. This ensures accurate identification and differentiation from other compounds in scientific literature.
Keywords that Ignite Curiosity:
When it comes to exploring Pitolisant on Google, several captivating keywords emerge:
Groundbreaking narcolepsy treatment: Discover the transformative potential of Pitolisant for individuals with narcolepsy.
Pitolisant vs. competitors: Compare the unique features and advantages of Pitolisant against other wakefulness-promoting agents.
Revolutionary H3 inverse agonist: Uncover the fascinating mechanism of action behind Pitolisant's wakefulness-promoting effects.
Potential side effects and dosing: Gain insights into the safety and dosing guidelines for Pitolisant administration.
Promising therapeutic applications: Explore the expanding frontiers of Pitolisant beyond narcolepsy treatment.
The Competitive Landscape:
While Pitolisant dominates the wakefulness-promoting market, it's essential to acknowledge its competitive counterparts. Notable products in this space include Modafinil, Armodafinil, and Sodium Oxybate, each with its own set of benefits and limitations.
Unveiling the Health Benefits:
Pitolisant has been hailed as a breakthrough therapy for narcolepsy, thanks to its multifaceted health benefits. By promoting wakefulness, reducing excessive daytime sleepiness, and mitigating the frequency of cataplexy attacks, Pitolisant offers a new lease on life for those affected by narcolepsy.
Evaluating Potential Effects:
The chief mechanism of action behind Pitolisant lies in its ability to act as a selective histamine 3 receptor antagonist, facilitating the release of histamine and other neurotransmitters. As a result, Pitolisant enhances wakefulness, alertness, and overall cognitive performance.
Safety First:
Within clinical trials, Pitolisant has demonstrated a favorable safety profile, with the majority of adverse effects being mild to moderate in nature. These include headaches, nausea, anxiety, and insomnia. As with any medication, it is important to consult with a healthcare professional before starting Pitolisant to ensure its safe and effective use.
Navigating Dosing Information:
To harness the full benefits of Pitolisant, it is crucial to follow the recommended dosing guidelines. Starting with 9 mg once daily, with gradual titration based on individual response and tolerability, the maximum daily dose of 36 mg should not be exceeded. Special considerations are necessary for individuals with hepatic impairment or those taking specific medications.
Contradicting Contraindications:
While Pitolisant holds tremendous promise, it should not be used in individuals with severe hepatic impairment or hypersensitivity to the active substance. Caution must also be exercised when combining Pitolisant with certain medications metabolized by CYP3A4 enzymes.
Conclusion:
Pitolisant, with its unique chemical structure, remarkable health benefits, and favorable safety profile, stands at the forefront of innovation in sleep disorder treatment. As research continues to uncover its full potential, Pitolisant emerges as a beacon of hope, heralding a new era of wakefulness promotion and improved quality of life. With the potential to transcend narcolepsy and explore new therapeutic applications, Pitolisant paves the way for a brighter future in sleep medicine
